Ultra-processed foods (UPFs ) account for a significant portion of energy intake in Western countries—in the United States, an estimated more than half. Given this ubiquity and a growing number of observational studies linking high UPF consumption to cardiometabolic diseases, the American Heart Association (AHA) issued its first comprehensive statement on the matter in 2025 in the form of a Science Advisory. The tone is noteworthy: The AHA carefully evaluates the evidence, warns against overinterpretation, and deliberately refrains from making blanket recommendations. For cardiologists and primary care physicians, it is worthwhile to understand this nuanced stance—precisely because the issue is often sensationalized in public discourse.
Publikation
- Ernährung/Adipositas-Special
Related Topics
You May Also Like
- Neuropathic Pain
Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Juvenile Idiopathic Arthritis
Early Detection and Targeted Treatment in an Interdisciplinary Setting
- Disorders of the Gut-Brain Interaction
Rome V Criteria: What Has Changed, and What Has Remained the Same?
- Tourette Syndrome
What can be done to treat this tic disorder?
- Chronic Hepatitis B: Is a Cure in Sight?
Phase III Trial of Temporary Treatment with Bepirovirsen Was Successful
- Congenital Vascular Malformations
Personalized Treatment Before a Planned Pregnancy
- Fibromyalgia Syndrome